Modified Nucleosides
Isocytidine
Quick view. We supply Isocytidine as a specialty product for nucleic acid chemistry and oligonucleotide research workflows. CAS 489-59-8. Catalog target purity: Specification on request.
Product profile
Isocytidine is classified as nucleoside or protected nucleoside intermediate (Formula C9H13N3O5; molecular weight 243.22).
Isocytidine can serve as a starting material, protected intermediate or analytical comparator in nucleoside and nucleotide route development.
For Isocytidine, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Confirmed or normalized name variants
- iso-Cr
- Isocytidine(6CI,8CI)
- 2-AMino-1-β-D-ribofuranosyl-4(1H)-pyriMidinone
- 4(1H)-Pyrimidinone, 2-amino-1-β-D-ribofuranosyl-
- 2-Amino-1-beta-D-ribofuranosyl-4(1H)-pyrimidinone
- 2-amino-1-(beta-D-ribofuranosyl)pyrimidin-4(1H)-one
- Isocytidine,2-Amino-1-beta-D-ribofuranosyl-4(1H)-pyrimidinone
Useful catalog search terms
- CAS 489-59-8
- Nucleoside or protected nucleoside intermediate
- Modified Nucleosides
Physicochemical data
| InChI | InChI=1S/C9H13N3O5/c10-9-11-5(14)1-2-12(9)8-7(16)6(15)4(3-13)17-8/h1-2,4,6-8,13,15-16H,3H2,(H2,10,11,14)/t4-,6-,7-,8-/m1/s |
|---|---|
| InChIKey | RGNOTKMIMZMNRX-XVFCMESISA-N |
| SMILES | C1=CN(C(=NC1=O)N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- Typical work includes protection/deprotection studies, phosphorylation or phosphitylation route scouting and impurity identification.
- The material can support medicinal-chemistry analog preparation and process-development feasibility studies.
Related products
(S)-cEt-rA
Modified Nucleosides · CAS: 1197033-34-3
BX-OP-0069S-Adenosylmethionine (SAM)
Modified Nucleosides · CAS: 485-80-3
BX-MN-0185(R-/S-) 5-Carbamoylhydroxy methyluridine
Modified Nucleosides · CAS: N/A
BX-MN-0186(R-/S-)5-(1-Hydroxy)(methoxycarbonyl)methyl uridine
Modified Nucleosides · CAS: N/A
BX-MN-0187(R-/S-)5-Carboxyhydroxymethyl uridine
Modified Nucleosides · CAS: N/A
BX-MN-0719(R)-N-(2,3-dihydro-1H-indenyl)adenosine
Modified Nucleosides · CAS: 96392-15-3
Frequently asked questions
Can the package size for Isocytidine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-MN-0552 and CAS 489-59-8, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the Modified Nucleosides product family and its named chemistry.